| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032834 Administering a chloroquine compound as an anticarcinogenic, antiischemic, anticholesterol, or anxiolytic agent |
| 02/10/2005 | US20050032736 Immunostimulatory nucleic acid molecules |
| 02/10/2005 | US20050032729 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus |
| 02/10/2005 | US20050032724 Multidrug Resistance Protein 1 (MRP1); mutagenesis |
| 02/10/2005 | US20050032696 Muscle transcription factors |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032256 Semiconductor device with porous interlayer insulating film |
| 02/10/2005 | US20050032223 Generating site directed DNA breaks in transformed cells via expression of heterologous endonuclease; bioreactor for generating exogenous proteins; gene therapy |
| 02/10/2005 | US20050032214 Cell-specific expression/replication vector |
| 02/10/2005 | US20050032208 Materials and methods to produce stem cells |
| 02/10/2005 | US20050032204 Microreactor architecture and methods |
| 02/10/2005 | US20050032197 Cell comprising transmembrane kinase for use in identifyiing modulators which effect protein-protein interaction; drug screening |
| 02/10/2005 | US20050032194 Protease deficient caulobacter host cells |
| 02/10/2005 | US20050032192 Products containing quantum of bioparticles and method for production thereof |
| 02/10/2005 | US20050032190 Beta-secretase substrates and uses thereof |
| 02/10/2005 | US20050032185 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents |
| 02/10/2005 | US20050032172 Expression vector comprising nucleotide sequences coding tumor necrosis factor (FTHMA-) and/or axon guidance receptor (T85) for use in identifying modulators for prevention and/or treatment of cell proliferative or neurological disorders |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032169 Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032165 Potassium channels, nucleotide sequences encoding them, and methods of using same |
| 02/10/2005 | US20050032163 Expression vector comlprising nucleotide sequences coding endostatins for use in prevention and treatment of cell proliferative disorders; antitumor agents |
| 02/10/2005 | US20050032161 Novel xanthine phosphoribosyl transferase |
| 02/10/2005 | US20050032158 Using novel g-protein coupled taste receptor (T1R2) as tools in identifying modulators to use as additives which enhance sweetness of foods consumed by animal and humans |
| 02/10/2005 | US20050032156 Identification and characterization of phosphate transporter genes |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032150 A-beta-peptide screening |
| 02/10/2005 | US20050032149 Enzyme catalyzed isotope labeling |
| 02/10/2005 | US20050032147 Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes |
| 02/10/2005 | US20050032146 Tssk4: a human testis specific serine/threonine kinase |
| 02/10/2005 | US20050032145 Spectrophotometric assay; incubating a mixture of said amidotransferase, fructose 6-phosphate, and glutamine to form glutamine-6-phosphate, acetylating to to form N-acetylglucosamine, reacting with Ehrlich's reagent, measuring optical density; use in high throughput microtiter plate analysis |
| 02/10/2005 | US20050032144 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking |
| 02/10/2005 | US20050032142 Protocol and apparatus for determining heparin-induced thrombocytopenia |
| 02/10/2005 | US20050032141 Dry analytical element for high-density lipoprotein cholesterol quantification |
| 02/10/2005 | US20050032139 Screening for ubiquitination modulators including proteins, peptides, polypeptides and/or drugs, comprising mixing labelled ubiquiting, modulators, ubiquitin activating enzymes and ubiquitin conjugating enzymes, then analyzing binding, in the presence and absence of the modulators |
| 02/10/2005 | US20050032138 Using monoclonal antobody to identify presence of prion protein in bodily fluids; immunodiagnostics and detection of spongiform encephalopathies |
| 02/10/2005 | US20050032137 Screening for potential anti-bacterial agents which are antagonists of the transpeptidase enzyme involved in peptidoglycan biosynthesis in bacteria |
| 02/10/2005 | US20050032136 Method for identifying endocrine disruptors and kit for carrying out the same |
| 02/10/2005 | US20050032131 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 02/10/2005 | US20050032129 Detection of antigen by immunohistochemical staining |
| 02/10/2005 | US20050032125 Constitutively translocating cell line |
| 02/10/2005 | US20050032124 Designing animal model to identify agents that selectively suppresses toxicity to neuronal cells for use in developing treatments for neurodegenerative diseases; neuroprotectants |
| 02/10/2005 | US20050032120 Fluorescent through-bond energy transfer cassettes based on xanthine and pyronin derivatives |
| 02/10/2005 | US20050032118 2-nitrobenzyloxycarbonyl-protein conjugates; antibody attached to labile residue(s) which reduce the ability of the antibody to bind to its binding partner, said labile residues can be dissociated by electromagnetic radiation, restoring antibody binding; use in tissue-targeted therapy, diagnosis |
| 02/10/2005 | US20050032115 Using microarray comprised of immobilized ligands to classify bacterial and viral pathogens and their toxic biopolymers; microbial receptors and ligand binding |
| 02/10/2005 | US20050032111 Using intregral membrane protein concentration as diagnostic and/or prognostic indicator of successful pregnancy; in vitro fertilization and reproductive disorders |
| 02/10/2005 | US20050032110 Screening agents capable of modulating cell phenotypes; using nucleotide sequence primer and restriction endonuclease enzyme |
| 02/10/2005 | US20050032109 Polypeptide activator for use as tool in treatment of thrombosis; treatment diagnosis of blood disorders |
| 02/10/2005 | US20050032108 Methods for genome annotation |
| 02/10/2005 | US20050032107 Method of screening anti-mycobacterial molecules |
| 02/10/2005 | US20050032106 Thermodynamics; probes; quantitative analysis |
| 02/10/2005 | US20050032104 Library of consecutive overlapping polynucleotide sequences from DNA sample for use in determining positon, distance and chromosomal location of preferential gene sequences |
| 02/10/2005 | US20050032102 Mapping genomic rearrangements |
| 02/10/2005 | US20050032101 Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/10/2005 | US20050032100 Electrochemical method and resulting structures for attaching molecular and biomolecular structures to semiconductor micro and nanostructures |
| 02/10/2005 | US20050032099 Using presence of cadherins in biological fluids as diagnostic indicator of cell proliferative disorders; immunodiagnostics |
| 02/10/2005 | US20050032096 Using variations in gene expression profiles of hypertensive patient to determine efficacy of hypotensive agents |
| 02/10/2005 | US20050032093 Novel genes involved in the escherichia coli biofilm formation and uses thereof |
| 02/10/2005 | US20050032092 Juxtaposing affinity moieties to a semiconductor to effect changes in the charge pair separation characteristics when the affinity molecules are bound to the target; detecting target moieties in situ using nanocrystalline semiconductors; genome sequencing, forensics, assays, and drug screening |
| 02/10/2005 | US20050032091 Using fluorescence in-situ hybridization to detect gene sequences associated with infection, cell proliferative, respiratory and blood disorders |
| 02/10/2005 | US20050032090 Detection of Giardia |
| 02/10/2005 | US20050032089 Preparing biochip for monitoring concentration of triglycerides, glucose and/or cholesterol in blood; bioassay |
| 02/10/2005 | US20050032085 Novel chromophores/fluorophores and methods for using the same |
| 02/10/2005 | US20050032082 Using amplified fragment-length polymorphisms (AFLP) or random-amplified polymorphic DNA (RAPD) as tool in determining gene compliment and classifiying preferential eukaryotes |
| 02/10/2005 | US20050032081 Solid phase synthesis; biocatalysts |
| 02/10/2005 | US20050032080 Method for quantifying a target nucleic acid |
| 02/10/2005 | US20050032077 Using polymorphisms in interleukin mapping positions as diagnostic indicators of vision defects associated with pancreatic disorders |
| 02/10/2005 | US20050032076 Polymerase chain reactions; exonucleases; microfluidics |
| 02/10/2005 | US20050032075 Determining sequence of polynucleotide using pyrophosphate extension reaction; identifying single nucleotide polymorphisms |
| 02/10/2005 | US20050032074 Custom design method for resequencing arrays |
| 02/10/2005 | US20050032073 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 02/10/2005 | US20050032072 Fragmentation and labelling with a programmable temperature control module |
| 02/10/2005 | US20050032071 RNA surveillance among curated proteins |
| 02/10/2005 | US20050032070 Polymorphisms in the human gene for CYP2D6 and their use in diagnostic and therapeutic applications |
| 02/10/2005 | US20050032069 RNA-induced silencing complexes; RNA interference; gene expression inhibition |
| 02/10/2005 | US20050032068 Oligomers hybridize with each other, one of which includes peptide nucleic acid or mimic, a morpholino nucleic acid, hexose sugar with amide linkage, cyclohexenyl nucleic acid or an acyclic backbone modification; gene expression inhibition |
| 02/10/2005 | US20050032067 Nucleosides; RNA-induced silencing complex; RNA interference; gene expression inhibition |
| 02/10/2005 | US20050032066 Method for assessing risk of diseases with multiple contributing factors |
| 02/10/2005 | US20050032065 Methods of prognosis of prostate cancer |
| 02/10/2005 | US20050032064 Method and device for identifying substances capable of modulating adipocyte differentiation |
| 02/10/2005 | US20050032063 Detection of matrix metalloproteinase rna in plasma and serum |
| 02/10/2005 | US20050032062 Methods for the assessment and prognosis of sarcoidosis |
| 02/10/2005 | US20050032061 Method of storing and/or delivering an oligomer and/or polymer applied on a support, and supports thereof |
| 02/10/2005 | US20050032060 Arrays comprising pre-labeled biological molecules and methods for making and using these arrays |
| 02/10/2005 | US20050032058 Using aberrant homeobox gene expression in hematopoietic cells as diagnostic indicator of cell proliferfative disorders |
| 02/10/2005 | US20050032057 Methods for preparing nucleic acid samples |
| 02/10/2005 | US20050032056 Identification and use of conserved noncoding sequences |
| 02/10/2005 | US20050032055 Methods of making nucleic acid molecules with reduced secondary structure |
| 02/10/2005 | US20050032054 Screening for novel bioactivities |
| 02/10/2005 | US20050032053 Hydrogen bonding; hybridization; synthesized via RNA/DNA polymerase reverse transcriptase, ribozyme, and/or self-replicating RNA molecule |
| 02/10/2005 | US20050032052 Methods and apparatus for extracting data from and optical analysis disc |
| 02/10/2005 | US20050032051 Multicompartment apparatus comprising magnetic beads with immobilized antibodies for use in small volume multi-antigen analysis; high throughput assay |
| 02/10/2005 | US20050032050 Using sequence data to generate oligonucleotides sharing sequence homology to stress resistance genes and which can be used to screen and isolate clones comprising complimentary sequences in plant genomic libraries |
| 02/10/2005 | US20050032049 Electrochemical method for detecting nucleic acids |
| 02/10/2005 | US20050032048 Analyzing polynucleotide sequences |
| 02/10/2005 | US20050032047 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay |
| 02/10/2005 | US20050032046 Using immortalized cells which express viral cell surface receptor as diagnostic models for screening viricidal agents; drug screening |
| 02/10/2005 | US20050032045 Viral fusion protein comprising a portion of gut associated lymphoid tissue (GALT) cell surface binding protein for use in targeted protein delivery and immunotherapeutics; vaccines |